Skip to content

Comparative Analysis of CSF inflammatory markers following Percutaneous Balloon Compression in Idiopathic Trigeminal Neuralgia

Comparative Analysis of CSF inflammatory markers following Percutaneous Balloon Compression in Idiopathic Trigeminal Neuralgia: An Interventional Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/027452
Enrollment
40
Registered
2020-08-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G500- Trigeminal neuralgia

Interventions

Intervention1: Per cutaneous Balloon compression: It is an intervention to manage pain associated with Trigeminal neuralgia. This therapy will be given ones the patient have been enrolled in the study

Sponsors

AIIMS Rishikesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age more than 18 years, History of hemi facial pain limited to trigeminal nerve distribution fulfilling the ICHD-III guidelines, Neuropathic (TN) pain unresponsive to oral medications, Pain involving ophthalmic division of trigeminal nerve, Pain involving more than one division of trigeminal nerve Numerical rating score of >=5. Informed consent.

Exclusion criteria

Exclusion criteria: 1. Patient refusal to participate. 2. Coagulopathy and/or patients on anticoagulants. 3. Infection at the site of injection. 4. Hypersensitivity to local anesthetic agent or radiographic contrast agents. 5. Evidence of severe psychiatric illness. 6. Pregnancy 7. Presence of red flag.

Design outcomes

Primary

MeasureTime frame
To compare and analyze the levels of inflammatory biomarkers in CSF of TN patients following Percutaneous Balloon Compression.Timepoint: Baseline and After 3 months of Intervention

Secondary

MeasureTime frame
1. Pain relief as assessed by Numerical Rating Scale (NRS) and Barrow Neurological Institute (BNI) pain intensity scale score. 2. To identify any correlation between intensity of pain and inflammatory markers. 3. The recurrence of pain following Percutaneous Balloon Compression. 4. Emotional functioning assessed by hospital anxiety and depression scale (HADS). 5. To assess any adverse effects and the complications due to the procedure. Timepoint: At the beginning, immediately after intervention and 3 month after the intervention.

Countries

India

Contacts

Public ContactRavi Shankar Sharma

All India Institute Of Medical Sciences,Rishikesh

ajitdr.ajit@gmail.com9910789377

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026